SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-06-052919
Filing Date
2006-08-09
Accepted
2006-08-09 12:06:35
Documents
5
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT PURSUANT TO SECTIONS 13 OR 15(D) a06-15256_110q.htm 10-Q 517099
2 EX-10 a06-15256_1ex10d55.htm EX-10.55 98582
3 EX-31 a06-15256_1ex31d1.htm EX-31.1 16746
4 EX-31 a06-15256_1ex31d2.htm EX-31.2 18142
5 EX-32 a06-15256_1ex32.htm EX-32 7587
  Complete submission text file 0001104659-06-052919.txt   659663
Mailing Address ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258
Business Address ONE SW COLUMBIA STE 1105 PORTLAND OR 97258 5032270554
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 061016095
SIC: 2834 Pharmaceutical Preparations